by Vandana Singh | Feb 23, 2026 | General
Teva Pharmaceuticals Industries Ltd (NYSE:TEVA) on Friday announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for olanzapine extended-release injectable suspension. Potential FDA Approval For Schizophrenia Drug The...
by Khyathi Dalal | Feb 23, 2026 | General
Despite a 30% drop over the past month, technical and on-chain data suggest XRP (CRYPTO: XRP) may be nearing a potential rebound zone. CryptocurrencyTickerPriceMarket Cap7-Day TrendXRP(CRYPTO: XRP)$1.41$86.2 billion-6.3%Bitcoin(CRYPTO: BTC)$66,273.24$1.32...
by Namrata Sen | Feb 23, 2026 | General
Former U.S. Deputy Assistant Attorney General John Yoo said that the Supreme Court’s (SCOTUS) ruling against President Donald Trump‘s tariffs might turn out to be advantageous for the Republican Party ahead of the 2026 midterms. Yoo believes the court’s decision could...
by Rishabh Mishra | Feb 23, 2026 | General
Applied Materials Inc. (NASDAQ:AMAT) has solidified its position as a premier semiconductor powerhouse, with its Benzinga Edge quality score surging to 90.89 following a blowout first-quarter earnings report. Stellar Q1 Results Drive Rankings Shift The ranking...
by Avi Kapoor | Feb 23, 2026 | General
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Monday. Shares of Novo Nordisk A/S (NYSE:NVO) fell sharply in pre-market trading after the company disclosed headline results from REDEFINE 4, an open-label phase 3 trial...
Recent Comments